Percy H. Carter serves as Executive at Blueprint Medicines Corp, where they oversee executive responsibilities. Since joining the company, Percy H. Carter has executed 13 insider transactions totaling $1.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 3, 2025 involved selling 1,051 shares valued at $134.8K.
Percy H. Carter currently holds 53,155 shares of Blueprint Medicines Corp (BPMC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Percy H. Carter has been a net seller of BPMC stock. They have purchased $0 and sold $1.3M worth of shares.
Percy H. Carter's most recent insider trade was on Jul 3, 2025, when they sold 1,051 shares at $128.25 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 5, 2024 | BPMC | $420.5K | Sale | 4,000 | $105.13 | Discretionary |
| Jun 3, 2024 | BPMC | $259.3K | Sale | 2,436 | $106.43 | Discretionary |
| Mar 7, 2024 | BPMC | $207.3K | Sale | 2,286 | $90.69 | Discretionary |
| Mar 1, 2024 | BPMC | $0 | Award | 12,500 | $N/A | Discretionary |
| Jun 5, 2023 | BPMC | $120.1K | Sale | 2,307 | $52.06 | Discretionary |
| Mar 6, 2023 | BPMC | $1.1K | Sale | 25 | $44.78 | Discretionary |
| Mar 6, 2023 | BPMC | $33.6K | Sale | 736 | $45.72 | Discretionary |
| Mar 1, 2023 | BPMC | $0 | Award | 12,500 | $N/A | Discretionary |
| Jun 6, 2022 | BPMC | $114.0K | Sale | 1,908 | $59.76 | Discretionary |
| Mar 1, 2022 | BPMC | $0 | Award | 8,750 | $N/A | Discretionary |
| Jun 1, 2021 | BPMC | $0 | Award | 21,843 | $N/A | Discretionary |